Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Solutions 2 Saline Solution 2 Hydrogen Peroxide 2 plerixafor 1 human papillomavirus vaccine, L1 type 16, 18 1 Vaccination 1 VP-102 1 Sodium Chloride 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Cantharidin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Warts × VP-102 × Clear all

NCT07246590 2026-01-21

COVE-2

Verrica Pharmaceuticals Inc.

Phase 3 Recruiting

Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡